Vaccines (Basel)
October 2024
Objectives: This study aimed to determine the safety, tolerability and immunogenicity of TetraFluBet, an inactivated subunit influenza vaccine that contains a corpuscular immuno-adjuvant derived from natural betulin.
Methods: We conducted a prospective, randomized, open-labeled, single-center, phase I trial. The study was conducted in two stages: 5 volunteers in stage I and 25 volunteers in stage II.
J Opt Soc Am A Opt Image Sci Vis
February 2024
Freeform dielectric waveguides connect optical chips made of different materials in fully integrated photonic devices. With a spatial extent in the order of 100 µm, they constitute a computational challenge and make Maxwell full-wave solvers unhandy for the accelerated design. Therefore, it is of utmost importance to have tools that permit the fast prediction of waveguide loss to enable the rapid optimization of waveguide trajectories.
View Article and Find Full Text PDFSince the onset of the COVID-19 pandemic, humanity has experienced the spread and circulation of several SARS-CoV-2 variants that differed in transmissibility, contagiousness, and the ability to escape from vaccine-induced neutralizing antibodies. However, issues related to the differences in the variant-specific immune responses remain insufficiently studied. The aim of this study was to compare the parameters of the humoral immune responses in two groups of patients with acute COVID-19 who were infected during the circulation period of the D614G and the Delta variants of SARS-CoV-2.
View Article and Find Full Text PDFBackground: Radiation therapy (RT) is an important step in the treatment of primary breast cancer as it is one of the leading contributors to cancer incidence among women. Most patients with this disease acquire radiation-induced lymphopenia in the early post-radiation period; however, little is known about the effect of RT on the composition of lymphocyte populations in such patients. This study was aimed at investigating the effect of adjuvant remote RT-performed in the classical mode for patients with primary breast cancer-on the main components of cell-mediated immunity (major lymphocyte populations), including those in patients receiving chemotherapy.
View Article and Find Full Text PDF